JP Morgan 2019 - Conference Review

The 37th annual JP Morgan Healthcare Conference took place in San Francisco, CA from January 7-10, 2019. A list of events and catalysts that were announced or updated at the conference are included in this report, as well as key points from the company presentations, and a summary of the State of the Industry Briefing on cell and gene therapies, which was also held in San Francisco, CA.

Highlights from the company presentations are included for: 

Mega Cap

• Novartis (NVS)
• Pfizer (PFE)
• Merck KGaA (MKGAY)

Large Cap

• Abbott Labs (ABT)
• AbbVie (ABBV)
• Alexion Pharmaceuticals (ALXN)
• Allergan (AGN)
• Amgen (AMGN)
• Astellas (4503:JP)
• Biogen (BIIB)
• BioMarin(BMRN)
• Boston Scientific (BSX)
• Bristol Myers (BMY)
• Celgene (CELG)
• CSL Ltd (CSL:AU)
• Daiichi Sankyo (4568.T)
• Dexcom (DXCM)
• Gilead (GILD)
• GlaxoSmithKline (GSK)
• Incyte (INCY)
• Ipsen SA (IPSEY)
• Jazz (JAZZ)
• Medtronic (MDT)
• Mylan N.V. (MYL)
• Regeneron (REGN)
• Sanofi (SNY)
• Teva Pharmaceuticals (TEVA)
• Vertex (VRTX)
• Zimmer Biomet (ZBH)

Mid Cap

• Acadia Pharmaceuticals (ACAD)
• Acceleron (XLRN)
• Alkermes (ALKS)
• Allogene Therapeutics (ALLO)
• Alnylam (ALNY)
• Amarin Corporation (AMRN)
• Arena Pharmaceuticals (ARNA)
• argenx (ARGX)
• Array (ARRY)
• Ascendis (ASND)
• bluebird bio (BLUE)
• Dynavax Technologies (DVAX)
• Evotec AG (EVT.DE)
• Galapagos NV (GLPG)
• Global Blood Therapeutics (GBT)
• GW Pharmaceuticals (GWPH)
• Halozyme Therapeutics (HALO)
• Immunomedics Inc (IMMU)
• Intercept Pharmaceutical (ICPT)
• Lee's Pharmaceutical Holdings (0950.HK)
• Moderna Therapeutics (MRNA)
• Morphosys AG (MOR)
• Nektar Therapeutics (NKTR)
• Neurocrine Biosciences (NBIX)
• Novocure (NVCR)
• Sage Therapeutics (SAGE)
• Santen (SZD.F)
• Sarepta (SRPT)
• Seattle Genetics (SGEN)
• United Therapeutics (UTHR)

Small Cap/Private

• Acorda Therapeutics (ACOR)
• Alder Biotherapeutics (ALDR)
• AMAG Pharmaceuticals (AMAG)
• Amicus Therapeutics (FOLD)
• AnaptysBio (ANAB)
• Coherus Biosciences (CHRS)
• Five Prime Therapeutics (FPRX)
• Idera Pharmaceuticals (IDRA)
• ImmunoGen (IMGN)
• Insys Therapeutics (INYS)
• Intra-Cellular Therapies (ITCI)
• Ironwood Pharmaceuticals (IRWD)
• Karyopharm (KPTI)
• Mallinckrodt (MNK)
• Molecular Partners AG (MOLN.SW)
• MyoKardia (MYOK)
• PTC Therapeutics (PTCT)
• Replimune (REPL)
• Rubius Therapeutics (RUBY)
• Sangamo Therapeutics (SGMO)
• Sienna Biopharmaceuticals (SNNA)
• Solid Biosciences (SLDB)
• Supernus Pharmaceuticals (SUPN)
• TG Therapeutics (TGTX)
• Tricida (TCDA)
• Urogen Pharmaceuticals (URGN)
• Y-mAbs Therapeutics (YMAB)
• Ziopharm Oncology (ZIOP)

Micro Cap/Private

• Adverum Biotechnologies (ADVM)
• Axovant Sciences (AXON)
• Basilea Pharmaeuticals (BSLN.SW)
• FLX Bio
• Kala Pharmaceuticals (KALA)
• ORIC Pharmaceuticals
• Springworks

For the full report, please download the PDF version. 

For our disclosures, please read the Biomedtracker Research Standards.